This content is for informational and educational purposes only. Peptides discussed on this page are research compounds not approved by the FDA for human use. Always consult a licensed medical professional before using any peptide or supplement.

Tirzepatide Dosage Chart: Complete Week-by-Week Schedule with mL & Unit Conversions

If you're looking for a clear tirzepatide dosage chart, you've come to the right place. This guide covers the full titration schedule from the 2.5 mg starting dose up to the 15 mg maximum, mL volume calculations for reconstituted tirzepatide at 5 mg/mL, unit conversions for insulin syringes, and a side-effects breakdown by dose level. Whether you're working with a physician-prescribed pen or researching reconstituted tirzepatide, every number you need is below.

Quick Reference: Tirzepatide starts at 2.5 mg weekly for 4 weeks, then increases by 2.5 mg every 4 weeks up to a maximum of 15 mg/week. Use our Dose Calculator to get your exact volume based on your vial concentration.

What Is Tirzepatide and Why Does Dosing Matter?

Tirzepatide is a dual GIP/GLP-1 receptor agonist originally approved as Mounjaro for type 2 diabetes and later as Zepbound for weight loss. By mimicking two gut hormones simultaneously, it suppresses appetite more powerfully than single-agonist options like semaglutide. Clinical trials showed average weight loss of 15–21% depending on dose, with higher doses producing greater results.

The reason dosing is so critical: tirzepatide's side effects—primarily nausea, vomiting, and GI discomfort—are dose-dependent. Starting too high triggers side effects that cause people to quit. The slow escalation protocol exists specifically to build tolerance. Skipping steps or rushing escalation is the number-one reason people abandon the medication prematurely.

Tirzepatide's half-life is approximately 5 days, which is why weekly dosing maintains stable plasma levels. Each weekly injection builds on the last, with steady-state concentrations reached around week 4. This pharmacokinetic profile also means that missing a dose doesn't cause immediate loss of effect — but consistency over weeks and months is what drives meaningful outcomes.

Tirzepatide Dosage for Weight Loss vs. Type 2 Diabetes

The titration schedule is the same whether you're taking tirzepatide for weight loss (Zepbound) or type 2 diabetes (Mounjaro). The primary difference lies in the maintenance dose target and how your provider determines when to stop escalating:

• Weight loss (Zepbound): Maintenance doses approved by FDA are 5 mg, 10 mg, or 15 mg. Your provider typically escalates until you achieve target weight loss velocity or reach your maximum tolerated dose.
• Type 2 diabetes (Mounjaro): The maintenance dose is whichever dose keeps your HbA1c within target range. Some patients are well-controlled at 5 mg; others need 10–15 mg for adequate glycemic control.
• Sleep apnea (Zepbound): The FDA-approved maintenance doses for obstructive sleep apnea are 10 mg and 15 mg — lower doses are not indicated for this specific condition.

For research peptide applications, the same escalation schedule serves as the standard reference protocol. Always consult a licensed medical professional before initiating any tirzepatide protocol.

The Official Tirzepatide Dosage Chart (Branded: Zepbound / Mounjaro)

The standard FDA-approved titration schedule for tirzepatide is identical for Zepbound and Mounjaro. The table below reflects the approved escalation protocol:

Phase	Weeks	Dose (Once Weekly)	Notes
Starter	Weeks 1–4	2.5 mg	Initiation dose — do not use for glycemic control; tolerance-building only
Escalation 1	Weeks 5–8	5 mg	Increase if 2.5 mg is tolerated; first active therapeutic dose
Escalation 2	Weeks 9–12	7.5 mg	Increase if 5 mg is tolerated and additional control needed
Escalation 3	Weeks 13–16	10 mg	Increase if 7.5 mg is tolerated and additional control needed
Escalation 4	Weeks 17–20	12.5 mg	Increase if 10 mg is tolerated and additional control needed
Maintenance (Max)	Week 21+	15 mg	Maximum approved dose — do not exceed

Important: You are not required to reach 15 mg. Many people find their optimal maintenance dose at 5 mg, 10 mg, or 12.5 mg. Your provider will determine the right stopping point based on your response and side-effect profile.

Research Tirzepatide Dosage Chart: mL Volumes at 5 mg/mL Concentration

Reconstituted (research peptide) tirzepatide is typically supplied as a lyophilized powder that you reconstitute with bacteriostatic water. The most common working concentration is 5 mg/mL. Use the table below to determine how many milliliters and insulin-syringe units to draw for each dose.

Need help with reconstitution math? Our Reconstitution Calculator does the math automatically once you enter your vial size and how much BAC water to add.

Weeks	Dose	Volume to Draw (at 5 mg/mL)	Insulin Syringe Units (100u/mL syringe)	Injection Notes
1–4	2.5 mg	0.50 mL	50 units	Single injection site
5–8	5 mg	1.00 mL	100 units	Single injection or split across two sites
9–12	7.5 mg	1.50 mL	150 units	Split across two injection sites recommended
13–16	10 mg	2.00 mL	200 units	Split across two injection sites
17–20	12.5 mg	2.50 mL	250 units	Split across two injection sites
21+	15 mg	3.00 mL	300 units	Split across two or three injection sites

Note on higher doses: Volumes above 1.0 mL are large for a single subcutaneous injection. Consider using a higher concentration (e.g., 10 mg/mL) so volume stays under 1 mL. Use the Reconstitution Calculator to find the right BAC water volume for your target concentration.

Tirzepatide Dose Conversion Chart: mg to mL to Units

One of the most-searched questions is "how many units is tirzepatide" — because insulin syringes are marked in units, not milligrams. The conversion depends entirely on your vial concentration. Here is a full reference table:

Dose (mg)	At 5 mg/mL mL | Units	At 10 mg/mL mL | Units	At 20 mg/mL mL | Units
2.5 mg	0.50 mL | 50u	0.25 mL | 25u	0.13 mL | 13u
5 mg	1.00 mL | 100u	0.50 mL | 50u	0.25 mL | 25u
7.5 mg	1.50 mL | 150u	0.75 mL | 75u	0.38 mL | 38u
10 mg	2.00 mL | 200u	1.00 mL | 100u	0.50 mL | 50u
12.5 mg	2.50 mL | 250u	1.25 mL | 125u	0.63 mL | 63u
15 mg	3.00 mL | 300u	1.50 mL | 150u	0.75 mL | 75u

Always confirm your exact concentration before drawing. One dose error at the wrong concentration can mean a 2–4x overdose or underdose. Use the Dose Calculator to eliminate manual math errors entirely.

Side Effects by Dose Level

Understanding which side effects are most common at which doses helps you manage your escalation intelligently. The table below is based on clinical trial data from the SURMOUNT-1 and SURPASS trials:

Dose	Nausea	Vomiting	Diarrhea	Constipation	Risk Notes
2.5 mg	Mild (10–15%)	Rare (<5%)	Mild	Rare	Generally well tolerated; tolerance-building phase
5 mg	Mild–Moderate (15–20%)	Low (5–8%)	Moderate	Mild	First active dose; GI effects emerge
7.5 mg	Moderate (20–25%)	Moderate (8–12%)	Moderate	Moderate	GI peak window; slow escalation if needed
10 mg	Moderate (22–28%)	Moderate (10–14%)	Moderate	Moderate	Monitor for gastroparesis symptoms
12.5 mg	Moderate–High (25–30%)	High (12–16%)	Moderate–High	Moderate	Extend 4-week window if needed before escalating
15 mg	Varies (20–30%)	Varies (10–18%)	Moderate	Moderate	Maximum dose; do not exceed. Body often adapts over time.

Serious side effects to watch for at any dose:

• Severe abdominal pain (possible pancreatitis — seek immediate care)
• Signs of hypoglycemia (especially if combined with insulin or sulfonylureas)
• Rapid heart rate or palpitations
• Severe allergic reaction (rash, swelling, difficulty breathing)
• Vision changes or worsening diabetic retinopathy

Managing common side effects: Eat smaller, slower meals. Avoid high-fat, greasy, or spicy foods on injection day. Stay well-hydrated. If nausea persists beyond 7–10 days at a new dose, consult your provider about extending that dose level before escalating further.

What Is the Maximum Tirzepatide Dose?

The FDA-approved maximum tirzepatide dose is 15 mg once weekly. This ceiling applies to both Zepbound (weight loss indication) and Mounjaro (diabetes indication). Going beyond 15 mg has not been studied in humans and offers no additional benefit while significantly increasing risk of adverse events.

A common misconception: people assume higher must be better. Clinical data shows diminishing returns above 10–12.5 mg for most patients. In the SURMOUNT-1 trial, the difference in weight loss between 10 mg and 15 mg was approximately 2 percentage points (19% vs. 21%). For many people, the side effect burden of 15 mg isn't worth that marginal gain.

Your optimal dose is the lowest dose at which you are achieving your goals with acceptable tolerability — not necessarily the maximum.

Missed Dose Protocol

Missing a weekly injection happens. Here is the correct procedure:

1. Missed dose within 4 days (96 hours): Inject as soon as you remember. Then resume your normal weekly injection day.
2. Missed dose 5 or more days ago: Skip the missed dose entirely. Do not double-dose. Resume your regular injection schedule on your next scheduled day.
3. Missed multiple doses in a row (2+ weeks): Contact your healthcare provider. You may need to step back down to a lower dose to re-establish tolerance before resuming your current dose level.
4. Switching injection day: If you need to permanently move your injection day, allow at least 3 days between injections when making the switch — never less.
5. Never inject two doses in one day to compensate for a missed dose.

For research peptide tirzepatide users following a similar protocol, the same rules apply. The half-life of tirzepatide is approximately 5 days, so missing one weekly injection does not immediately erase progress — but consistency maximizes results.

How to Use the Tirzepatide Dose Calculator

Calculating mL and units manually is error-prone, especially as you change vial concentrations or move to multi-dose vials. Our Tirzepatide Dose Calculator handles everything automatically:

1. Enter your target dose in milligrams (e.g., 5 mg)
2. Enter your vial concentration (e.g., 5 mg/mL or 10 mg/mL)
3. Select your syringe type (insulin syringe 100u/mL or TB syringe)
4. The calculator outputs your exact mL volume and unit marking to draw to

This eliminates the most common source of dosing errors in research settings. Bookmark the Dose Calculator on your phone so it's available at injection time.

If you are starting from a raw lyophilized powder, use the Reconstitution Calculator first to determine how much bacteriostatic water to add for your desired concentration.

Tirzepatide for Research: Key Differences from Branded Pens

Branded Zepbound and Mounjaro come as pre-filled autoinjector pens with a fixed concentration — you simply dial and inject. Research tirzepatide requires you to:

• Reconstitute the lyophilized powder with bacteriostatic water
• Calculate your volume based on the resulting concentration
• Draw into a separate insulin or TB syringe
• Store correctly: refrigerated after reconstitution, typically stable 28–60 days
• Track dose escalation manually using a chart like this one

For a complete step-by-step protocol, see our Tirzepatide Dosing Guide, which covers reconstitution, injection technique, storage, and rotation sites in detail. If you are exploring lower experimental doses, see our guide on microdosing tirzepatide.

Tirzepatide Injection Sites and Technique

Tirzepatide is administered as a subcutaneous injection — meaning into the fatty tissue just beneath the skin, not into muscle. Approved injection sites are:

• Abdomen: At least 2 inches away from the navel. Most accessible site for self-injection.
• Upper thigh: Outer surface of either thigh. Slightly slower absorption than abdomen.
• Upper arm: Outer area only. Typically requires assistance for self-injection.

Rotate injection sites with each weekly dose. Never inject into the same spot two weeks in a row — rotation prevents lipohypertrophy (fatty lumps that reduce absorption). Keep a simple log of which site you used each week. For higher doses (1.5 mL or more), split the volume across two sites to reduce local discomfort and improve absorption consistency.

Tirzepatide vs. Semaglutide: Dosage Comparison

Many researchers transition from semaglutide to tirzepatide. The dosing schedules are similar (both weekly, both start-low-go-slow), but there is no direct mg-to-mg conversion. Tirzepatide generally produces stronger weight loss results at equivalent points in the titration schedule due to its dual-agonist mechanism. Do not attempt to equate doses between the two compounds.

A rough clinical comparison: 2.5 mg tirzepatide is considered roughly equivalent in appetite suppression to 0.25–0.5 mg semaglutide (Ozempic starting dose). At maximum doses (15 mg vs. 2.4 mg semaglutide), tirzepatide typically delivers 3–5 percentage points more weight loss on average. This is not a substitution guide — it is simply context for researchers familiar with semaglutide who are evaluating tirzepatide.

Frequently Asked Questions

How many units is 2.5 mg of tirzepatide?

It depends on your concentration. On a standard 100-unit insulin syringe (1 mL = 100 units):

• At 5 mg/mL: 2.5 mg = 0.50 mL = 50 units
• At 10 mg/mL: 2.5 mg = 0.25 mL = 25 units
• At 20 mg/mL: 2.5 mg = 0.13 mL = 13 units

Always verify your vial's concentration label before drawing. Use the Dose Calculator to eliminate guesswork.

How many units is 5 mg of tirzepatide?

At common concentrations:

• At 5 mg/mL: 5 mg = 1.00 mL = 100 units
• At 10 mg/mL: 5 mg = 0.50 mL = 50 units
• At 20 mg/mL: 5 mg = 0.25 mL = 25 units

What is the tirzepatide dosage in units on an insulin syringe?

"Units" on an insulin syringe correspond to microliters, not milligrams. 100 units = 1.0 mL. Your milligram dose divided by your concentration (mg/mL) gives you the volume in mL. Multiply by 100 to get insulin syringe units. Example: 7.5 mg ÷ 10 mg/mL = 0.75 mL × 100 = 75 units.

Can I stay at a lower dose instead of going up to 15 mg?

Absolutely. The maximum dose is a ceiling, not a target. Many people achieve excellent results and maintain their weight at 5 mg, 7.5 mg, or 10 mg. There is no clinical requirement to escalate to the highest tolerated dose if a lower dose is working. Your provider will help you identify your optimal maintenance dose.

How long does it take to see results on tirzepatide?

Most people notice appetite suppression within the first 1–2 weeks even at the 2.5 mg starter dose. Meaningful weight loss typically becomes visible by week 8–12 (once therapeutic doses are reached). Maximum results are generally seen at 52–72 weeks.

What happens if I miss two or more weeks of tirzepatide?

After two or more missed weeks, your GI tolerance resets. Returning to your previous dose can trigger the same severe nausea you experienced early on. Step back down one dose level and re-escalate over 4 weeks. Never return directly to your previous dose after a multi-week gap without medical guidance.

Is compounded tirzepatide the same as Zepbound or Mounjaro?

Compounded tirzepatide contains the same active peptide but is not FDA-approved and lacks the same quality controls as branded formulations. Purity, concentration accuracy, and sterility vary by source. Always purchase from suppliers that provide third-party certificates of analysis (COA) with >98% purity documentation.

Can I inject tirzepatide daily instead of weekly?

No. Tirzepatide is designed and dosed for once-weekly subcutaneous injection. Daily dosing would dramatically increase systemic exposure and side effects. The molecule's 5-day half-life is what makes weekly dosing effective. Some researchers explore microdosing tirzepatide with smaller, more frequent injections — but this deviates significantly from standard protocol and lacks clinical validation.

Where to Source Research Tirzepatide

For those sourcing tirzepatide as a research peptide, quality matters enormously. Look for suppliers that provide third-party HPLC testing, a verifiable Certificate of Analysis, US-based fulfillment, and clear concentration labeling. Ascension Peptides is one supplier that meets these standards for researchers seeking tirzepatide peptides.

Remember: concentration labeling errors are the most common source of dosing mistakes. Verify every vial's documentation before use.